XINGANJIANG
873167
INNOVATIVE DATA
835305
CHENGUANG MEDICAL
430300
4
Hangzhou Gaoxin Materials Technology
300478
5
Beijing Philisense Technology
300287
(FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Current assets | ||||||||||
Cash, cash equivalents and short term investments | -12.18%188.2M | -12.18%188.2M | -9.98%269.6M | -82.81%251.5M | -83.21%198.4M | -72.97%214.3M | -72.97%214.3M | -84.19%299.5M | -49.19%1.46B | -63.50%1.18B |
-Cash and cash equivalents | -12.18%188.2M | -12.18%188.2M | -9.98%269.6M | -82.81%251.5M | -83.21%198.4M | -72.97%214.3M | -72.97%214.3M | -84.19%299.5M | -49.19%1.46B | -63.50%1.18B |
Receivables | 5.49%1.04B | 5.49%1.04B | 8.84%994.5M | 7.78%911.7M | 20.04%906.9M | 12.20%984M | 12.20%984M | 19.81%913.7M | 12.02%845.9M | -14.58%755.5M |
-Accounts receivable | 6.65%885.1M | 6.65%885.1M | 10.02%821.2M | 8.11%739.9M | 21.36%763.5M | 14.55%829.9M | 14.55%829.9M | 18.42%746.4M | 8.89%684.4M | -16.71%629.1M |
-Taxes receivable | -46.33%25.6M | -46.33%25.6M | -22.10%43M | -10.11%48M | -1.18%25.2M | -21.80%47.7M | -21.80%47.7M | 64.78%55.2M | 151.89%53.4M | 32.81%25.5M |
-Other receivables | 19.64%127.3M | 19.64%127.3M | 16.24%130.3M | 14.52%123.8M | 17.15%118.2M | 16.28%106.4M | 16.28%106.4M | 13.46%112.1M | 2.56%108.1M | -8.27%100.9M |
Inventory | 1.85%120.8M | 1.85%120.8M | 5.31%129M | 9.15%128.8M | 9.57%126M | 6.56%118.6M | 6.56%118.6M | 21.29%122.5M | 27.57%118M | -43.27%115M |
Other current assets | 18.97%195.7M | 18.97%195.7M | 18.01%199.2M | 10.48%198.2M | 7.94%194.4M | 8.72%164.5M | 8.72%164.5M | 21.79%168.8M | 16.49%179.4M | 11.93%180.1M |
Total current assets | 4.14%1.54B | 4.14%1.54B | 5.84%1.59B | -42.82%1.49B | -36.13%1.43B | -23.34%1.48B | -23.34%1.48B | -62.31%1.5B | -47.79%2.61B | -50.24%2.23B |
Non current assets | ||||||||||
Net PPE | 25.17%149.7M | 25.17%149.7M | 35.10%132.8M | 24.23%116.4M | 38.59%119.6M | 40.21%119.6M | 40.21%119.6M | 18.15%98.3M | 21.22%93.7M | -12.74%86.3M |
-Gross PPE | ---- | ---- | ---- | ---- | ---- | 15.39%388.4M | 15.39%388.4M | ---- | ---- | ---- |
-Accumulated depreciation | ---- | ---- | ---- | ---- | ---- | -6.96%-268.8M | -6.96%-268.8M | ---- | ---- | ---- |
Goodwill and other intangible assets | 12.01%28.37B | 12.01%28.37B | 12.16%28.48B | 13.65%26.96B | 13.88%27.14B | 5.65%25.33B | 5.65%25.33B | 27.49%25.39B | 19.40%23.72B | 15.99%23.83B |
-Goodwill | 12.82%19.31B | 12.82%19.31B | 13.02%19.27B | 14.44%18.31B | 14.71%18.31B | 7.35%17.12B | 7.35%17.12B | 24.68%17.05B | 17.96%16B | 13.25%15.96B |
-Other intangible assets | 10.32%9.06B | 10.32%9.06B | 10.42%9.21B | 12.00%8.65B | 12.19%8.83B | 2.26%8.21B | 2.26%8.21B | 33.64%8.34B | 22.51%7.72B | 21.96%7.87B |
Investments and advances | -2.94%772.3M | -2.94%772.3M | 19.31%878.6M | 42.53%842.8M | 59.35%852.5M | 48.73%795.7M | 48.73%795.7M | --736.4M | --591.3M | --535M |
Non current deferred assets | 68.01%54.1M | 68.01%54.1M | -31.09%35.9M | -36.31%30.7M | -47.39%31.2M | -42.40%32.2M | -42.40%32.2M | 10.38%52.1M | 4.10%48.2M | -41.52%59.3M |
Other non current assets | 8.76%443.4M | 8.76%443.4M | 6.83%433.2M | 2.30%409M | 5.24%407.8M | 3.11%407.7M | 3.11%407.7M | 12.92%405.5M | 8.82%399.8M | -3.34%387.5M |
Total non current assets | 11.64%29.79B | 11.64%29.79B | 12.28%29.96B | 14.09%28.36B | 14.66%28.55B | 6.54%26.69B | 6.54%26.69B | 30.76%26.68B | 22.08%24.85B | 17.74%24.9B |
Total assets | 11.24%31.33B | 11.24%31.33B | 11.94%31.55B | 8.69%29.85B | 10.48%29.98B | 4.40%28.17B | 4.40%28.17B | 15.54%28.19B | 8.32%27.46B | 5.85%27.13B |
Liabilities | ||||||||||
Current liabilities | ||||||||||
Payables | -27.28%216.5M | -27.28%216.5M | 0.45%202.8M | -11.36%180.3M | 33.35%272.7M | 26.09%297.7M | 26.09%297.7M | -28.18%201.9M | -53.69%203.4M | -78.72%204.5M |
-accounts payable | 3.57%148.1M | 3.57%148.1M | 14.73%155.8M | 5.88%149.4M | 8.36%145.2M | 16.64%143M | 16.64%143M | 12.05%135.8M | 9.55%141.1M | -20.14%134M |
-Total tax payable | -5.26%68.4M | -5.26%68.4M | -28.90%47M | -50.40%30.9M | 80.85%127.5M | 82.78%72.2M | 82.78%72.2M | -58.66%66.1M | -79.93%62.3M | -91.11%70.5M |
-Dividends payable | ---- | ---- | ---- | ---- | ---- | 11.49%82.5M | 11.49%82.5M | ---- | ---- | ---- |
Current accrued expenses | 124.13%546.2M | 124.13%546.2M | 20.26%468.4M | 18.28%469.7M | 12.29%464.2M | -7.13%243.7M | -7.13%243.7M | 6.54%389.5M | 2.35%397.1M | 0.10%413.4M |
Current debt and capital lease obligation | 92.17%1.04B | 92.17%1.04B | 40.00%699M | -28.55%500M | -28.56%499.7M | -27.20%542.8M | -27.20%542.8M | -28.56%499.3M | -12.51%699.8M | -12.51%699.5M |
-Current debt | 108.83%1.04B | 108.83%1.04B | 40.00%699M | -28.55%500M | -28.56%499.7M | -28.56%499.5M | -28.56%499.5M | -28.56%499.3M | -12.51%699.8M | -12.51%699.5M |
-Current capital lease obligation | ---- | ---- | ---- | ---- | ---- | -6.68%43.3M | -6.68%43.3M | ---- | ---- | ---- |
Current deferred liabilities | 6.65%1.74B | 6.65%1.74B | 11.65%1.67B | 14.73%1.47B | 15.64%1.51B | 14.75%1.63B | 14.75%1.63B | 42.71%1.5B | 15.80%1.28B | 16.38%1.3B |
Current liabilities | 29.33%3.83B | 29.33%3.83B | 16.96%3.29B | 1.59%2.81B | 4.83%2.91B | 2.44%2.96B | 2.44%2.96B | -0.98%2.81B | -12.70%2.76B | -20.74%2.78B |
Non current liabilities | ||||||||||
Long term debt and capital lease obligation | 12.85%6.58B | 12.85%6.58B | 20.36%7.68B | 16.05%6.92B | 21.09%7.22B | -2.21%5.83B | -2.21%5.83B | 7.02%6.38B | -10.38%5.97B | -10.37%5.96B |
-Long term debt | 12.85%6.58B | 12.85%6.58B | 20.36%7.68B | 16.05%6.92B | 21.09%7.22B | -2.21%5.83B | -2.21%5.83B | 7.02%6.38B | -10.38%5.97B | -10.37%5.96B |
Non current deferred liabilities | 7.77%1.63B | 7.77%1.63B | 6.72%1.65B | -0.25%1.59B | -1.69%1.62B | -9.76%1.51B | -9.76%1.51B | 13.26%1.55B | 12.88%1.59B | 11.98%1.65B |
Other non current liabilities | 2.07%424.4M | 2.07%424.4M | 2.04%420M | -0.89%391.4M | 3.62%424.2M | 1.12%415.8M | 1.12%415.8M | 10.23%411.6M | 0.61%394.9M | -9.26%409.4M |
Total non current liabilities | 11.28%8.63B | 11.28%8.63B | 16.92%9.75B | 11.95%8.9B | 15.51%9.27B | -3.61%7.76B | -3.61%7.76B | 8.28%8.34B | -6.00%7.95B | -6.47%8.03B |
Total liabilities | 16.27%12.47B | 16.27%12.47B | 16.93%13.04B | 9.28%11.71B | 12.76%12.18B | -2.01%10.72B | -2.01%10.72B | 5.79%11.15B | -7.82%10.71B | -10.61%10.8B |
Shareholders'equity | ||||||||||
Share capital | 0.00%1.1M | 0.00%1.1M | 0.00%1.1M | 0.00%1.1M | 0.00%1.1M | 0.00%1.1M | 0.00%1.1M | 0.00%1.1M | 0.00%1.1M | 0.00%1.1M |
-common stock | 0.00%1.1M | 0.00%1.1M | 0.00%1.1M | 0.00%1.1M | 0.00%1.1M | 0.00%1.1M | 0.00%1.1M | 0.00%1.1M | 0.00%1.1M | 0.00%1.1M |
-Preferred stock | ---- | ---- | ---- | ---- | ---- | --0 | --0 | ---- | ---- | ---- |
Retained earnings | 8.22%16.03B | 8.22%16.03B | 7.95%15.66B | 8.02%15.37B | 8.44%15.12B | 7.91%14.82B | 7.91%14.82B | 22.17%14.51B | 22.56%14.23B | 22.18%13.94B |
Paid-in capital | 8.95%3.01B | 8.95%3.01B | 9.29%2.98B | 10.08%2.92B | 10.38%2.84B | 10.23%2.77B | 10.23%2.77B | 10.37%2.72B | 9.85%2.66B | 8.74%2.57B |
Less: Treasury stock | -1.79%16.5M | -1.79%16.5M | -2.37%16.5M | -2.35%16.6M | -2.34%16.7M | -2.33%16.8M | -2.33%16.8M | -2.31%16.9M | -2.30%17M | -2.29%17.1M |
Gains losses not affecting retained earnings | -35.59%-166.5M | -35.59%-166.5M | 39.25%-107.4M | -12.71%-142.8M | 12.89%-141.9M | 34.33%-122.8M | 34.33%-122.8M | 62.28%-176.8M | 55.98%-126.7M | 20.92%-162.9M |
Total stockholders'equity | 8.16%18.87B | 8.16%18.87B | 8.67%18.52B | 8.32%18.14B | 8.97%17.8B | 8.77%17.44B | 8.77%17.44B | 22.95%17.04B | 22.00%16.75B | 20.52%16.33B |
Total equity | 8.16%18.87B | 8.16%18.87B | 8.67%18.52B | 8.32%18.14B | 8.97%17.8B | 8.77%17.44B | 8.77%17.44B | 22.95%17.04B | 22.00%16.75B | 20.52%16.33B |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |